Luxist Web Search

Search results

1. Results From The WOW.Com Content Network

2. Eli Lilly and Company - Wikipedia

   en.wikipedia.org/wiki/Eli_Lilly_and_Company

   Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union Army veteran of the American Civil War for whom the company was later named.

3. Eli Lilly - Wikipedia

   en.wikipedia.org/wiki/Eli_Lilly

   Eli Lilly (July 8, 1838 – June 6, 1898) was an American soldier, pharmacist, chemist, and businessman who founded the Eli Lilly and Company pharmaceutical corporation. Lilly enlisted in the Union Army during the American Civil War and recruited a company of men to serve with him in the 18th Independent Battery Indiana Light Artillery .

4. Lilly Endowment - Wikipedia

   en.wikipedia.org/wiki/Lilly_Endowment

   Lilly Endowment Inc., headquartered in Indianapolis, Indiana, is one of the world's largest private philanthropic foundations and among the largest endowments in the United States. It was founded in 1937 by Josiah K. (J. K.) Lilly Sr. and his sons, Eli Jr. and Josiah Jr. (Joe), with an initial gift of Eli Lilly and Company stock valued at ...

5. Eli Lilly reports $2 billion from Mounjaro, Zepbound in Q1 ...

   www.aol.com/finance/eli-lilly-reports-2-billion...

   Eli Lilly ( LLY) missed Wall Street consensus estimates on Mounjaro sales for the first quarter of the year, but its GLP-1 products, including Zepbound, still contributed to 26% sales growth year ...

6. How the CFOs of Eli Lilly and Novo Nordisk are coping with ...

   www.aol.com/finance/cfos-eli-lilly-novo-nordisk...

   Indianapolis-based Eli Lilly (no. 142 on the Fortune 500) is the maker of Mounjaro, classified as Type 2 diabetes drug but which has led to weight loss among patients, and Zepbound, an obesity ...

7. Eli Lilly CEO: 'I think a bet on Lilly is to bet we can keep ...

   www.aol.com/finance/eli-lily-ceo-think-bet...

   After a record year in 2023, Eli Lilly — fueled by the success of its GLP-1 drug, tirzepatide, used in Mounjaro for diabetes and Zepbound for obesity — isn't slowing down in the space, knowing ...